Evolution of Analytical Procedure Validation Concepts: Part I

Publication
Article
BioPharm InternationalBioPharm International Quality and Regulatory Sourcebook 2023
Volume 2023 eBook
Issue 1
Pages: 14–21

This article provides an overview of validation concept principles evolution to a life cycle risk-based approach with focus on compendial perspectives.

Hand holding wooden block with tick mark, satisfaction survey ,mental health assessment, checklist business, project tracking, goal tracker, task completion concept. Image Credit: ©sewcream - sewcream-stock.adobe.com

sewcream - Stock.adobe.com

In recent years, regulatory agencies have placed an increased emphasis on pharmaceutical process understanding through adoption of quality-by-design (QbD) principles by launching a series of initiatives to encourage the pharmaceutical industry to adopt QbD in the manufacturing process. A key component of this transformation is the evolution of validation concepts to a life cycle risk-based approach driven by analytical quality by design (AQbD) principles. Different pharmacopoeias have been developing compendial approaches to support the implementation of analytical procedure life cycle (APLC) risk-based approach. Additionally, the International Council for Harmonisation (ICH) released in March 2022 two draft guidelines for public consultation which outline QbD principles: ICH Q14 (procedure development) (1), and the ICH Q2(R2) (procedure validation) (2). In a series of two articles, the authors will provide an overview of the validation concept principles evolution with a focus on compendial perspectives (Part I) and draw a parallel between ICH Q14 and Q2(R2) and United States Pharmacopeia (USP) General Chapter <1220> and the ISO/IEC 17025:2017 (Part II).

Read the article in BioPharm International’s Quality and Regulatory Sourcebook March 2023

About the authors

Amanda Guiraldelli is scientific affairs manager at the United States Pharmacopeia.
Jane Weitzel is an independent consultant and chair of the US Pharmacopeia Expert Committee on Measurement and Data Quality.

Article details

BioPharm International
eBook: Quality and Regulatory Sourcebook 2023
March 2023
Pages: 14–21

Citation

When referring to this article, please cite it as Guiraldelli, A. and Weitzel, J. Evolution of Analytical Procedure Validation Concepts: Part I. BioPharm International Quality and Regulatory Sourcebook 2023. March 2023.

Articles in this issue
Standard quality control. Certification. Business, technology, internet and networking concept | Image Credit: © PHOTON_PHOTO - STOCK.ADOBE.COM
Mitigating Human Error and Supporting Compliance with Smart Technology
Murrstock - Stock.adobe.com
Phase-appropriate Analytical Methodology
Business process management, Businessman plan a project with wooden cubes with icon business strategy on blue background. copy space. Image Credit: ©Worawut -Worawut - Stock.adobe.com
Evolution of Analytical Procedure Validation Concepts: Part II
Pharmacovigilance Automation
Pharmacovigilance Automation
Hand holding wooden block with tick mark, satisfaction survey ,mental health assessment, checklist business, project tracking, goal tracker, task completion concept. Image Credit: ©sewcream - sewcream-stock.adobe.com
Evolution of Analytical Procedure Validation Concepts: Part I
relif - Stock.adobe.com
Points to Consider for Knowledge Management Acceleration
Recent Videos
Christa Myers, CRB Group; Nadiyra Walker Speight, Fujifilm Diosynth Biotechnologies
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Gives Recommendations Including Several Orphan Drugs for Approval in December

Susan Haigney
December 17th 2024
Article

EMA's committee gave recommendations for marketing authorization of 17 drugs in December, which include therapies for rare heart conditions, anemia, and liver disease.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk to Acquire Manufacturing Sites Upon Catalent Acquisition and Acquires Novavax’s Czech Republic Site

Feliza Mirasol
December 10th 2024
Article

The European Commission’s approval of the Catalent acquisition by Novo Holdings includes the related acquisition of three manufacturing sites by Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.

Shining Pro - Stock.Adobe.com

Enhancing Quality Through Training

Susan Haigney
December 7th 2024
Article

With so many personnel involved in the development and manufacture of pharmaceuticals, proper training of all staff is key to ensuring a quality product.

Growing Bacteria in Petri Dishes on agar gel Scientific experiment. | Image Credit: ©luchschenF- Stock.Adobe.com

Overcoming Viral Clearance Challenges

Cynthia A. Challener
December 5th 2024
Article

Many factors must be considered to overcome the challenges associated with viral clearance.

3d rendering. Empty blank black metal sphere balance scale on white background. | Image Credit: ©PATARA – stock.adobe.com

Comparability in Accelerated or Stressed Stability Studies Using a Quality Range

Richard K. Burdick
December 4th 2024
Article

A statistical procedure based on a quality range is proposed for demonstrating comparability between pre-change and post-change process slopes in an accelerated or stressed stability study.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

New Drug Shortages Monitoring Platform in Europe

Susan Haigney
December 4th 2024
Article

A new platform allowing market authorization holders to report drug shortages has gone live.

© 2024 MJH Life Sciences

All rights reserved.